Episode
Ep. 171: Pioneer, Generic, Compounded, and Counterfeit Animal Drugs with Stephanie Batliner
- Podcast
- Disease Du Jour
- Published
- Dec 4, 2025
- Duration seconds
- 1799
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/disease-du-jour-15968/episodes/ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/disease-du-jour-15968/ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss the FDA approval process for pioneer and generic animal drugs. She also discussed veterinary devices, pharmacy compounding, counterfeit drugs, and more. This episode of Disease Du Jour is brought to you by Bimeda. GUESTS AND LINKS - EPISODE 171 Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly ([email protected]) Guest: Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda Podcast Website: Disease Du Jour This episode of Disease Du Jour podcast is brought to you by Bimeda . Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly ([email protected])